C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Position in LLY — ELI LILLY & Co
CIK 1965756
Westlake, OH
Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,648,016
+$280,319 QoQ
Shares Held
1,374
-7.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#2,680
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors holds $11,231,670 across 7 Drug Manufacturers - General names. LLY ranks #3 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,281 | $5,103,510 | |
| 2 | JNJ |
Johnson & Johnson
|
7,826 | $1,987,569 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,374 | $1,648,016 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,782 | $871,487 | |
| 5 | PFE |
Pfizer Inc
|
32,587 | $784,694 | |
| 6 | AMGN |
Amgen Inc
|
1,561 | $565,269 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,146 | $271,125 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,648,016 | 1,374 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,367,697 | 1,487 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $4,864,002 | 4,526 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $4,138,512 | 5,424 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,204,373 | 1,545 | Shares | Sole | 2025-11-03 | |
| 2025-03-31 | $1,018,347 | 1,233 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,148,736 | 1,488 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,234,114 | 1,393 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,102,752 | 1,218 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,275,854 | 1,640 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $695,423 | 1,193 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $541,427 | 1,008 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $349,859 | 746 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $256,191 | 746 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $273,648 | 748 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||